SynthesisThe Cochrane database of systematic reviews2009
Antiviral treatment for Bell's palsy (idiopathic facial paralysis).
Synthesis in The Cochrane database of systematic reviews, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 40 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed, 6 syntheses or guidelines pooled it, 92 citations in OpenAlex.
- Physical therapy for facial nerve paralysis (Bell's palsy): An updated and extended systematic review of the evidence for facial exercise therapy.Clinical rehabilitation · 2022Pooled it
- Effectiveness comparisons of antiviral treatments for Bell palsy: a systematic review and network meta-analysis.Journal of neurology · 2022Pooled it
- Clinical practice guidelines in idiopathic facial paralysis: systematic review using the appraisal of guidelines for research and evaluation (AGREE II) instrument.Journal of neurology · 2021Pooled it
- Antiviral treatment for Bell's palsy (idiopathic facial paralysis).The Cochrane database of systematic reviews · 2019Pooled it
- Hyperbaric oxygen therapy for Bell's palsy.The Cochrane database of systematic reviews · 2012Pooled it
- Physical therapy for Bell's palsy (idiopathic facial paralysis).The Cochrane database of systematic reviews · 2011Pooled it
- Trial
- Trial
- Single dose intravenous methyl prednisolone versus oral prednisolone in Bell's palsy: a randomized controlled trial.Indian journal of pharmacologyTrial
- Corticosteroids and antiviral treatment for Bell's palsy (idiopathic facial paralysis).The Cochrane database of systematic reviews · 2026Article
- Bell's palsy characteristics, clinical manifestations, complications, and prognosis in a primary care setting, a single center study: A retrospective cohort study.Journal of family medicine and primary care · 2024Article
- Stylohyoid fracture resulting in facial paralysis.BMJ case reports · 2023Article
- Rare Diseases of the Salivary Glands and of Facial Nerve.Laryngo- rhino- otologie · 2021Article
- Etiology and therapy of delayed facial paralysis after middle ear surgery.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2020Review
- PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review.Cancers · 2019Review
- Facial Palsy, a Disorder Belonging to Influential Neurological Dynasty: Review of Literature.North American journal of medical sciences · 2016Review
- Measurement and analysis of associated mimic muscle movements.Journal of otology · 2015Article
- Facial nerve trauma: evaluation and considerations in management.Craniomaxillofacial trauma & reconstruction · 2015Review
- Nerve growth factor for Bell's palsy: A meta-analysis.Experimental and therapeutic medicine · 2015Article
- Steroid-antivirals treatment versus steroids alone for the treatment of Bell's palsy: a meta-analysis.International journal of clinical and experimental medicine · 2015Article
Corrections and comments
- Retraction · 2015-09-07Retract and Replace · Temporary Removal · Unreliable Data ·
- Commented on by
- Updated by
- Update of
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntiviral agents against herpes simplex virus are widely used in the treatment of idiopathic facial paralysis (Bell's palsy), but their effectiveness is uncertain. Significant morbidity can be associated with severe cases.
objectivesThis review addresses the effect of antiviral therapy on Bell's palsy. SEARCH STRATEGY: We updated the search of the Cochrane Neuromuscular Disease Group Trials Register (December 2008), MEDLINE (from January 1966 to December 8 2008), EMBASE (from January 1980 to December 8 2008) and LILACS (from January 1982 to December 2008). SELECTION CRITERIA: Randomized trials of antivirals with and without corticosteroids versus control therapies for the treatment of Bell's palsy. DATA COLLECTION AND ANALYSIS: Twenty-three papers were selected for consideration. MAIN
resultsSeven trials including 1987 participants met the inclusion criteria, adding five studies to the two in the previous review.Incomplete recovery at one year. There was no significant benefit in the rate of incomplete recovery from antivirals compared with placebo (n = 1886, RR 0.88, 95% CI 0.65 to 1.18). In meta-analyses with some unexplained heterogeneity, the outcome with antivirals was significantly worse than with corticosteroids (n = 768, RR 2.82, 95% CI 1.09 to 7.32) and the outcome with antivirals plus corticosteroids was significantly better than with placebo (n = 658, RR 0.56, 95% CI 0.41 to 0.76).Motor synkinesis or crocodile tears at one year. In single trials, there was no significant difference in long term sequelae comparing antivirals and corticosteroids with corticosteroids alone (n = 99, RR 0.39, 95% CI 0.14 to 1.07) or antivirals with corticosteroids (n = 101, RR 1.03, 95% CI 0.51 to 2.07).Adverse events.There was no significant difference in rates of adverse events between antivirals and placebo (n = 1544, RR 1.06, 95% CI 0.81 to 1.38), between antivirals and corticosteroids (n = 667, RR 0.96, 95% CI 0.65 to 1.41) or between the antiviral-corticosteroid combination and placebo (n = 658, RR 1.15, 95% CI 0.79 to 1.66). AUTHORS'
conclusionsHigh quality evidence showed no significant benefit from anti-herpes simplex antivirals compared with placebo in producing complete recovery from Bell's palsy. Moderate quality evidence showed that antivirals were significantly less likely than corticosteroids to produce complete recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.